Absence of familial defective apolipoprotein B-100 in Finnish patients with elevated serum cholesterolTiina Hämäläinen; Aarno Palotie; Katriina Aalto-Setälä; Kimmo Kontula; Matti J. Tikkanen · 1990

Absence of familial defective apolipoprotein B-100 in Israeli patients with dominantly inherited hypercholesterolemia and in offspring with parental history of myocardial infarctionYechiel Friedlander; Eldad J. Dann; Eran Leitersdorf · 1993

Phenotypic heterogeneity associated with defective apolipoprotein B-100 and occurrence of the familial hypercholesterolemia phenotype in the absence of an LDL-receptor defect within a Canadian kindredJ. Davignon; R. Dufour; M. Roy; C. Bétard; Y. Ma; S. Ouellette; L. Boulet; S. Lussier-Cacan · 1992

Supplement 1: European Atherosclerosis Congress (56th EAS Meeting), Santa Margherita di Pula, Cagliari, Italy, October 10-13, 1992 || Phenotypic Heterogeneity Associated with Defective Apolipoprotein B-100 and Occurrence of the Familial Hypercholesterolemia Phenotype in the Absence of an LDL-Receptor Defect within a Canadian KindredJ. Davignon, R. Dufour, M. Roy, C. Bétard, Y. Ma, S. Ouellette, L. Boulet and S. Lussier-Cacan · European Journal of Epidemiology · 1992

Plasma homocysteine level and development of coronary artery diseaseKawashiri, Masa-aki; Kajinami, Kouji; Nohara, Atsushi; Yagi, Kunimasa; Inazu, Akihiro; Koizumi, Junji; Haraki, Tatsuo; Takegoshi, Tadayoshi; Mabuchi, Hiroshi · Coronary Artery Disease · 1999

Effect of common methylenetetrahydrofolate reductase gene mutation on coronary artery disease in familial hypercholesterolemiaMasa-aki Kawashiri; Kouji Kajinami; Atsushi Nohara; Kunimasa Yagi; Akihiro Inazu; Junji Koizumi; Hiroshi Mabuchi · 2000